201 related articles for article (PubMed ID: 15895895)
1. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography.
Vaglio A; Greco P; Versari A; Filice A; Cobelli R; Manenti L; Salvarani C; Buzio C
Clin Exp Rheumatol; 2005; 23(2):231-4. PubMed ID: 15895895
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and follow-up of idiopathic retroperitoneal fibrosis: role of (18)F-FDG-PET/CT and biochemical parameters in patients with renal involvement.
Fofi C; Prosperi D; Pettorini L; Festuccia F; Pirisino R; Lanni V; Scopinaro F; Punzo G; Menè P
Intern Emerg Med; 2016 Sep; 11(6):809-16. PubMed ID: 26970988
[TBL] [Abstract][Full Text] [Related]
3. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
Jansen I; Hendriksz TR; Han SH; Huiskes AW; van Bommel EF
Eur J Intern Med; 2010 Jun; 21(3):216-21. PubMed ID: 20493425
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
[TBL] [Abstract][Full Text] [Related]
5. Persistent FDG/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse.
Morin G; Mageau A; Benali K; Bertinchamp R; Piekarski E; Raimbourg Q; Alexandra JF; Goulenok T; van Gysel D; Papo T; Sacre K
Eur J Intern Med; 2019 Apr; 62():67-71. PubMed ID: 30711361
[TBL] [Abstract][Full Text] [Related]
6. Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab.
Adam Z; Čermák A; Petrášová H; Řehák Z; Koukalová R; Fojtík Z; Pour L; Boichuk I; Krejčí M; Král Z; Benda P
Vnitr Lek; 2023; 69(E-3):4-15. PubMed ID: 37468330
[TBL] [Abstract][Full Text] [Related]
7. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases.
Young PM; Peterson JJ; Calamia KT
Ann Nucl Med; 2008 Jan; 22(1):87-92. PubMed ID: 18250993
[TBL] [Abstract][Full Text] [Related]
8. Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis.
Pipitone N; Versari A; Vaglio A; Salvarani C
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S72-8. PubMed ID: 21418782
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
[TBL] [Abstract][Full Text] [Related]
10. [The use of positron emission tomography (18F-FDG PET) in diagnosing chronic periaortitis].
Nemec P; Rehák Z; Fabián P; Soucek M
Vnitr Lek; 2008 Nov; 54(11):1093-9. PubMed ID: 19069683
[TBL] [Abstract][Full Text] [Related]
11. (18)F-Fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated with mediastinal fibrosis.
Washino S; Hirai M; Matsuzaki A; Kobayashi Y
Ann Nucl Med; 2010 Apr; 24(3):225-9. PubMed ID: 20112003
[TBL] [Abstract][Full Text] [Related]
12. [Mycophenolate mofetil combined with steroids: new experiences in the treatment of idiopathic retroperitoneal fibrosis].
Obrencević K; Jovanović D; Kovacević Z; Hrvacević R; Ignjatović L; Mijusković M
Vojnosanit Pregl; 2007 Jun; 64(6):385-90. PubMed ID: 17687942
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis.
Catanoso MG; Spaggiari L; Magnani L; Pipitone N; Versari A; Boiardi L; Pazzola G; Pattacini P; Salvarani C
Clin Exp Rheumatol; 2012; 30(5):776-8. PubMed ID: 23021007
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic Retroperitoneal Fibrosis With Intense Uptake of 68Ga-Fibroblast Activation Protein Inhibitor and 18F-FDG.
Pan Q; Luo Y; Zhang W
Clin Nucl Med; 2021 Feb; 46(2):175-176. PubMed ID: 33208623
[TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal fibrosis: single-centre experience from 1992 to 2010, current status of knowledge and review of the international literature.
Gómez García I; Sánchez Castaño A; Romero Molina M; Rubio Hidalgo E; García Betancourth N; Labra González R; Sampietro Crespo A; Álvarez Fernández F; Flores Herrero Á; Gómez Rodríguez A
Scand J Urol; 2013 Oct; 47(5):370-7. PubMed ID: 23206245
[TBL] [Abstract][Full Text] [Related]
16. Follow-up of FDG-PET/CT findings in retroperitoneal fibrosis associated with abdominal aortic aneurysm.
Wiggermann P; Aust D; Stroszczynski C; Kotzerke J; Zöphel K
Nuklearmedizin; 2011; 50(3):N21-2. PubMed ID: 21611677
[No Abstract] [Full Text] [Related]
17. FDG-PET/CT findings of autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis.
Otsuka H; Morita N; Yamashita K; Nishitani H
Ann Nucl Med; 2007 Dec; 21(10):593-6. PubMed ID: 18092136
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic Retroperitoneal Fibrosis: Long-term Risk and Predictors of Relapse.
Raffiotta F; da Silva Escoli R; Quaglini S; Rognoni C; Sacchi L; Binda V; Messa P; Moroni G
Am J Kidney Dis; 2019 Dec; 74(6):742-750. PubMed ID: 31204195
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnosis and Post-Therapeutic Treatment in a Patient with an Early Stage of Retroperitoneal Fibrosis.
Niccoli Asabella A; Nicoletti A; Altini C; Notaristefano A; Lastilla G; Rubini G
Mol Imaging Radionucl Ther; 2013 Aug; 22(2):60-2. PubMed ID: 24003399
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography as a tool for the 'tailored' management of retroperitoneal fibrosis: a nephro-urological experience.
Piccoli GB; Consiglio V; Arena V; Pelosi E; Anastasios D; Ragni F; Fiori C; Cortese G; Deagostini MC; Porpiglia F; Scarpa RM
Nephrol Dial Transplant; 2010 Aug; 25(8):2603-10. PubMed ID: 20157170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
